Upstream Bio, Inc. (UPB)
NASDAQ: UPB · Real-Time Price · USD
18.01
-4.73 (-20.80%)
Nov 20, 2024, 4:00 PM EST - Market closed
Upstream Bio Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Revenue | 2.21 | 2.38 | 1.21 |
| Revenue Growth (YoY) | 82.10% | 96.37% | - |
| Gross Profit | 2.21 | 2.38 | 1.21 |
| Selling, General & Admin | 15.24 | 10.7 | 6.46 |
| Research & Development | 52.75 | 31.8 | 18.66 |
| Operating Expenses | 67.98 | 42.49 | 25.12 |
| Operating Income | -65.78 | -40.11 | -23.91 |
| Interest & Investment Income | 8.57 | 4.17 | 0.21 |
| Other Non Operating Income (Expenses) | 3.81 | 15.41 | -0.16 |
| Pretax Income | -53.4 | -20.54 | -23.87 |
| Net Income | -53.4 | -20.54 | -23.87 |
| Preferred Dividends & Other Adjustments | 16.19 | 17.72 | - |
| Net Income to Common | -69.59 | -38.26 | -23.87 |
| Shares Outstanding (Basic) | 3 | 3 | 3 |
| Shares Outstanding (Diluted) | 3 | 3 | 3 |
| Shares Change (YoY) | 2.29% | 0.56% | - |
| EPS (Basic) | -24.30 | -13.59 | -8.52 |
| EPS (Diluted) | -24.30 | -13.59 | -8.52 |
| Free Cash Flow | -56 | -38.07 | -19.1 |
| Free Cash Flow Per Share | -19.55 | -13.52 | -6.82 |
| Gross Margin | 100.00% | 100.00% | 100.00% |
| Operating Margin | -2980.34% | -1685.46% | -1972.69% |
| Profit Margin | -3153.10% | -1607.35% | -1969.31% |
| Free Cash Flow Margin | -2537.20% | -1599.58% | -1576.16% |
| EBITDA | -65.72 | -40.05 | -23.9 |
| D&A For EBITDA | 0.05 | 0.06 | 0.01 |
| EBIT | -65.78 | -40.11 | -23.91 |
Source: S&P Capital IQ. Standard template.
Financial Sources.